X-spine Systems, a manufacturer of orthopedic medical devices for spinal surgery, has entered into an exclusive license agreement with Gamma Spine for the development and distribution of minimally invasive spinal fixation technology.
Reportedly, the patent-pending orthopedic device allows for the fixation of adjacent vertebral segments with minimal tissue disruption while attaining the biomechanical advantages of a traditional full-exposure system.
By entering into the license agreement, X-spine furthers its strategy to address the continuing market trend towards smaller, cost-effective procedures in spinal surgery.
Vijay Goel, founder of Gamma Spine, said: “X-spine is the ideal partner to bring this technology to the worldwide marketplace; the company has an excellent track record of bringing innovative technology to fruition through its top-down emphasis on engineering, research, and development.”
David Kirschman, president and CEO of X-spine, said: “I am thrilled be working with Dr Goel, who is one of the renowned and published experts in spinal biomechanics, to develop this valuable technology. The patent-pending device allows for the fixation of adjacent vertebral segments with minimal tissue disruption while attaining the biomechanical advantages of a traditional full-exposure system.
“Surgeons are demanding procedure options which are less invasive for patients, less costly for payers, but maintain the ease, safety and efficacy of traditional full-exposure procedures. We feel that the Gamma technology effectively addresses that demand.”